ZEPP
Zepp Health Corporation
NYSE · Technology · Consumer Electronics · CN
$4.80
+6.43%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9B | 1.8B | 1.3B | 352.6M | 615.7M |
| Cost of Revenue | 1.2B | 1.1B | 820.6M | 260.3M | 496.4M |
| Gross Profit | 753.9M | 711.6M | 512.9M | 92.3M | 119.4M |
| Operating Expenses | |||||
| R&D Expense | 232.8M | 317.7M | 337.1M | 51.5M | 76.9M |
| SG&A Expense | 659.8M | 582.6M | 520.8M | 71.3M | 103.5M |
| General & Admin Expense | 49.8M | — | 181.7M | 26.7M | 35.2M |
| Selling & Marketing Expense | 85.5M | — | 339.2M | 44.5M | 68.3M |
| Other Expenses | 100.8M | 16.2M | — | — | — |
| Total Operating Expenses | 993.5M | 916.6M | 857.9M | 122.7M | 180.3M |
| Cost and Expenses | 2.2B | 2.0B | 1.7B | 383.1M | 676.7M |
| Operating Income (EBIT) | (239.6M) | (204.9M) | (345.0M) | (30.4M) | (61.0M) |
| Non-Operating | |||||
| Interest Income | 7.8M | 10.7M | 26.8M | 3.1M | 1.8M |
| Interest Expense | 44.8M | 39.9M | 40.5M | 6.7M | 8.5M |
| Net Interest Income | (37.0M) | (29.2M) | (13.7M) | (3.7M) | (6.6M) |
| Other Non-Op Income/Expense | (44.3M) | (58.2M) | (108.6M) | (3.1M) | 8.2M |
| Non-Operating Income (excl Interest) | 20.8M | 18.3M | 37.3M | (2.6M) | (14.1M) |
| EBT (Pre-Tax Income) | (283.9M) | (263.1M) | (453.6M) | (33.5M) | (52.7M) |
| Income Tax Expense | 17.6M | 17.8M | 100.0M | (2.4M) | (9.8M) |
| Bottom Line | |||||
| Net Income | (301.5M) | (280.9M) | (554.1M) | (31.1M) | (42.8M) |
| Earnings from Cont. Ops | (301.5M) | (280.9M) | (553.6M) | (31.1M) | (43.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (301.5M) | (280.9M) | (553.0M) | (31.0M) | (42.8M) |
| Per Share | |||||
| Basic EPS | ($292.87) | ($283.04) | ($34.08) | ($0.28) | ($0.40) |
| Diluted EPS | ($292.87) | ($283.04) | ($34.08) | ($0.28) | ($0.40) |
| Revenue Per Share | $1,947.22 | $1,826.34 | $82.41 | $23.21 | $40.00 |
| Shares | |||||
| Basic Shares Outstanding | 989673 | 993873 | 16.2M | 15.2M | 15.4M |
| Diluted Shares Outstanding | 989673 | 993873 | 16.2M | 15.2M | 15.4M |
| Profitability Metrics | |||||
| EBITDA | (251.4M) | (191.5M) | (345.7M) | (20.2M) | (38.2M) |
| D&A | 8.9M | 31.7M | 36.6M | 7.7M | 8.7M |
| EBIT | (260.4M) | (223.2M) | (382.3M) | (27.9M) | (46.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026